<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adolf W Karchmer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vivian H Chu, MD, MHS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jay A Montgomery, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Traditionally, cardiac implantable electronic devices (CIEDs), including pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices with or without defibrillation capacity (CRT-D or CRT-P, respectively), have included pulse generators to provide the electrical stimulus and either transvenous or epicardial leads to deliver the stimulus to the heart. </p><p>Additional novel devices have been developed which operate effectively without the requirement for a transvenous or epicardial lead system; leadless pacemakers are percutaneously placed directly inside the heart, while subcutaneous ICDs and implantable loop recorders function effectively in an extrathoracic pocket without direct attachment to the heart. </p><p>The clinical presentation and management of CIED infections vary according to the location and extent of infection and the clinical characteristics of the patient [<a href="#rid1">1</a>]. This topic focuses on the epidemiology, microbiology, clinical manifestations, and diagnosis of CIED infections involving PPMs, ICDs, and CRT devices.</p><p>CIED infections are generally considered in two categories: pocket infection and systemic infection. These categories are not mutually exclusive, and the two forms may coexist. An alternative approach to classification of CIED infection is by mode of infection (eg, primary or secondary). Primary infection occurs when the device and/or pocket itself is the source of infection; this is the most common form of CIED infection and occurs as a result of contamination at the time of CIED implantation. Secondary infection occurs when the leads (and sometimes the device and the pocket) are seeded due to bacteremia from a remote source.</p><p>Issues related to treatment and prevention of CIED infections, as well as noninfectious complications of PPMs and ICDs, are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/116021.html" rel="external">"Infections involving cardiac implantable electronic devices: Treatment and prevention"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/989.html" rel="external">"Cardiac implantable electronic devices: Long-term complications"</a> and  <a class="medical medical_review" href="/d/html/108919.html" rel="external">"Cardiac implantable electronic devices: Periprocedural complications"</a>.)</p><p></p><p class="headingAnchor" id="H7878123"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H2"><span class="h2">Incidence</span><span class="headingEndMark"> — </span>The true incidence of CIED infection is difficult to determine due to the lack of a comprehensive registry or mandatory reporting. A range of values has been reported in a number of observational series [<a href="#rid2">2-8</a>]. In one review including 21 studies of CIED recipients with variable follow-up, the rate of infections ranged from 0.8 to 5.7 percent [<a href="#rid9">9</a>]. Data also suggest that increasing use of CIEDs has been associated with an increased incidence of device infection [<a href="#rid7">7,10</a>].</p><p>The following observations illustrate the range of findings: </p><p class="bulletIndent1"><span class="glyph">●</span>The incidence of infection was studied among 97,750 patients who underwent a total of 128,045 implantation or replacement procedures (100,374 pacemaker [PPM], 16,718 implantable cardioverter-defibrillator [ICD], 4630 cardiac resynchronization therapy-PPM [CRT-P], and 6323 cardiac resynchronization therapy-defibrillator [CRT-D] procedures) in Denmark between 1982 and 2018. After 566,275 device-years of surveillance, the following infection risks were identified [<a href="#rid11">11</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>PPM – 1.2 percent lifetime risk</p><p class="bulletIndent2"><span class="glyph">•</span>ICD – 1.9 percent lifetime risk</p><p class="bulletIndent2"><span class="glyph">•</span>CRT-P – 2.2 percent lifetime risk</p><p class="bulletIndent2"><span class="glyph">•</span>CRT-D – 3.4 percent lifetime risk</p><p></p><p class="bulletIndent1">Infection rates were lowest during the initial implantation, with infection rates 1.5 to 3-fold higher during revision or replacement procedures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Data from the United States National Inpatient Sample from 1993 to 2008 indicate an overall infection incidence of 1.6 percent; rates were stable until 2004, whereupon the incidence was noted to increase significantly [<a href="#rid10">10</a>]. Between 2000 and 2012, the average annual incidence of CIED infection in this database was 2.06 percent per patient-year [<a href="#rid12">12</a>]. Between 2003 and 2017, the annual proportion with CIED-related infectious endocarditis (CIED-IE) increased from 1.7 to 4.8 percent [<a href="#rid13">13</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a cohort of more than 200,000 patients enrolled in a CIED registry, 1.7 percent (3390 patients) developed an infection within six months post-implantation; the incidence was higher among patients who underwent pulse-generator replacement than among those who underwent initial implantation [<a href="#rid14">14</a>].</p><p></p><p>Patients admitted for CIED infection experience significant mortality:</p><p class="bulletIndent1"><span class="glyph">●</span>Among the 27,257 with CIED-IE in the 2003-2017 United States National Inpatient Sample, the overall in-hospital mortality was 9.2 percent; mortality for those with native valve or prosthetic valve endocarditis was 12 percent each. The longitudinal analysis revealed a significant reduction in CIED-IE mortality from 15 to 9.7 percent in 2003 and 2017, respectively [<a href="#rid13">13</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another study including 416 patients admitted with CIED infection noted mortality rates of 5.5 and 14.6 percent at 30 days and 1 year after admission, respectively [<a href="#rid15">15</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among more than 3,400 Medicare recipients undergoing initial CIED implantation or replacement who experienced device infection during the following year, 1-year mortality was noted in 17 percent of 2,109 patients treated with device extraction and replacement and 34 percent of 1,355 patients treated with device extraction in the absence of replacement [<a href="#rid16">16</a>]. </p><p></p><p class="headingAnchor" id="H739292992"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>A number of risk factors and comorbid conditions have been associated with CIED infection [<a href="#rid3">3,9,17-21</a>]. The most clearly identified risk factor is recent manipulation of the device (eg, newly implanted device, device revision or generator change). Other risk factors include the number of prior procedures, the lack of antibiotic prophylaxis at the time of implantation, immunocompromised state, renal dysfunction, younger age, and postprocedure hematoma [<a href="#rid21">21,22</a>].</p><p>Devices that have been in place for longer periods of time are less likely to become secondarily infected in the setting of bacteremia. Approximately 63 to 77 percent of infections occur within one year, and 23 to 37 percent occur after one year [<a href="#rid23">23</a>].</p><p>In one systematic review and meta-analysis, three major categories of risk factors were defined [<a href="#rid24">24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patient-related risk factors</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>End-stage kidney disease</p><p class="bulletIndent2"><span class="glyph">•</span>Previous device infection</p><p class="bulletIndent2"><span class="glyph">•</span>Corticosteroid use</p><p class="bulletIndent2"><span class="glyph">•</span>Chronic obstructive lung disease</p><p class="bulletIndent2"><span class="glyph">•</span>Malignancy</p><p class="bulletIndent2"><span class="glyph">•</span>Diabetes mellitus</p><p class="bulletIndent2"><span class="glyph">•</span>Heart failure</p><p class="bulletIndent2"><span class="glyph">•</span>Anticoagulant use</p><p class="bulletIndent2"><span class="glyph">•</span>Skin disorders</p><p class="bulletIndent2"><span class="glyph">•</span>Older age with comorbidities</p><p class="bulletIndent2"><span class="glyph">•</span>Pre-procedure fever</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Procedure-related risk factors</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Procedure duration</p><p class="bulletIndent2"><span class="glyph">•</span>Postoperative hematoma</p><p class="bulletIndent2"><span class="glyph">•</span>Reintervention for lead dislodgement</p><p class="bulletIndent2"><span class="glyph">•</span>Operator inexperience</p><p class="bulletIndent2"><span class="glyph">•</span>Temporary pacing</p><p class="bulletIndent2"><span class="glyph">•</span>Device replacement/revision</p><p class="bulletIndent2"><span class="glyph">•</span>Lack of antibiotic prophylaxis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Device-related characteristics:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Epicardial leads</p><p class="bulletIndent2"><span class="glyph">•</span>Abdominal pocket</p><p class="bulletIndent2"><span class="glyph">•</span>Positioning of two or more leads</p><p class="bulletIndent2"><span class="glyph">•</span>ICD, CRT-P, or CRT-D greater risk than PPM [<a href="#rid11">11,25</a>]</p><p></p><p class="headingAnchor" id="H7"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H176291398"><span class="h2">Causative organisms</span><span class="headingEndMark"> — </span><em>Staphylococcus aureus</em> and coagulase-negative staphylococci (often <em>Staphylococcus epidermidis</em>) cause the majority of generator pocket infections and up to 89 percent of device-related endocarditis (CIED-IE) [<a href="#rid5">5,26-29</a>]. The likelihood of <em>S. aureus</em> infection is high for CIED infections arising within two weeks of implantation [<a href="#rid30">30,31</a>]. Other organisms implicated in CIED infections include streptococci, enterococci, <em>Corynebacterium</em> spp, <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>)<em> acnes</em>, gram-negative bacilli, and <em>Candida</em> spp.</p><p class="bulletIndent1"><span class="glyph">●</span>In one study including more than 600 CIED infections, only 5 percent were caused by gram-negative bacilli (<em>Pseudomonas</em> <em>aeruginosa</em> and <em>Serratia </em>species being most common). Of these 31 patients, infection was limited to the pocket in 24 cases; and in the 7 patients with bloodstream infection, 6 had concurrent pocket infection [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study that included 412 patients with infected CIEDs (241 localized pocket infections and 171 endovascular infections without pocket inflammation); staphylococcal infections were the most common  (<a class="graphic graphic_table graphicRef55942" href="/d/graphic/55942.html" rel="external">table 1</a>) [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among 162 episodes of precisely defined pacemaker endocarditis from four studies, coagulase-negative staphylococci caused 61 percent and <em>S. aureus</em> caused 30 percent [<a href="#rid2">2,3,34,35</a>]. Methicillin resistance was common among the staphylococci. Polymicrobial infection occurred in 18 patients, and cultures were negative in 7 patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the Spanish Collaboration on Endocarditis that included 3,966 cases of endocarditis, 424 patients had CIED-IE. <em>S. aureus and</em> coagulase negative staphylococci each caused 30 percent of cases; other causes included enterococci (5 percent), streptococci (8 percent), gram negative bacilli (7 percent), <em>Candida spec</em>ies (2 percent). In contrast, the major causes for valvular endocarditis were <em>S. aureus (18</em> percent), coagulase negative staphylococci (21 percent), enterococci (19 percent), streptococci (22 percent), <em>Candida spe</em>cies (2 percent), and gram negative bacilli (7 percent) [<a href="#rid36">36</a>].</p><p></p><p class="headingAnchor" id="H1609933670"><span class="h2">Bacteremia</span><span class="headingEndMark"> — </span><em>S. aureus</em> bacteremia in patients with a CIED is associated with a relatively high rate of CIED infection, morbidity, and mortality [<a href="#rid13">13,37-39</a>]. It is likely that many of these patients have a primary infection of the CIED, particularly when bacteremia occurs in the initial three months after device manipulation. In addition, a significant number of individuals with <em>S. aureus</em> CIED lead infection also have concurrent valvular infection. Furthermore, secondary bacteremic seeding of the CIED from <em>S. aureus</em> infection occurring at a remote site is common. </p><p>Given the morbidity and mortality associated with <em>S. aureus</em> bacteremia generally and with CIED infection particularly, it is important that patients with a CIED who develop <em>S. aureus</em> bacteremia are carefully evaluated for CIED infection. (See <a class="local">'CIED systemic infection'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>In one study that applied the European Heart Rhythm Association’s CIED-IE diagnostic criteria [<a href="#rid1">1</a>] to 110 patients with a CIED and <em>S. aureus</em> bacteremia (inclusive of those with a pocket infections), definite and possible CIED-IE were diagnosed in 52 and 28 percent of cases, respectively [<a href="#rid40">40</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study including more than 360 patients with a CIED and <em>S. aureus </em>bacteremia, CIED infection was observed in 51 percent of patients. Among those without evidence of CIED infection who did not undergo empiric CIED removal, 19 percent had recurrent bacteremia. The risk of relapse correlated with the duration of bacteremia (&gt;1 day of bacteremia OR 9.99) [<a href="#rid41">41</a>].</p><p></p><p><em>Enterococcus faecalis</em> is a less common cause of CIED infection (compared with <em>S. aureus</em> and<em> S. epidermidis</em>); development of <em>E. faecalis</em> bacteremia in the context of CIED placement should prompt consideration of device infection:</p><p class="bulletIndent1"><span class="glyph">●</span>In one population-based cohort study including 72 patients with a CIED and monomicrobial <em>E. faecalis </em>bacteremia between 2014 and 2018, 4 underwent device extraction [<a href="#rid42">42</a>]. Of the 68 patients whose device was retained, recurrent of <em>E. faecalis b</em>acteremia occurred in 10 percent of cases. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Similarly, a prospective international observational registry of CIED infection including 433 patients noted enterococcal bacteremia in 4.8 percent of cases, most of whom had definite endocarditis [<a href="#rid43">43</a>]. The onset of infection was distant from the most recent device manipulation, suggesting that CIED infection likely arose by hematogenous seeding from a remote focus of infection.</p><p></p><p>Native valve endocarditis can occur independently or concurrently with CIED endocarditis/lead infection. This is of particular concern when patients have endocarditis-predisposing valvular lesions (native or prosthetic valve). In one study, 12 of 45 bacteremic patients with a CIED had only valvular endocarditis; in 6 of the 12 patients, the causative organism was a streptococcus [<a href="#rid3">3</a>]. Thus, in patients with unexplained bacteremia due to streptococcus or enterococcus (eg, organisms that commonly causes endocarditis), evidence of independent valvular infection should be sought. (See <a class="local">'Endocarditis'</a> below.).</p><p>CIED lead/valve infection caused by gram-negative organisms is rare [<a href="#rid44">44,45</a>]. Occasionally, gram-negative bacilli cause pocket infection due to direct introduction during device implantation or revision, and such an infection could give rise to bacteremia. However, gram-negative bacteremia from sources other than the CIED pocket rarely seed the device pocket or leads. Thus, in the absence of evidence of pocket infection or CIED-IE, patients with gram-negative bacteremia from a remote site can be managed initially with device retention [<a href="#rid44">44,46</a>]. However, in patients managed with CIED retention, recurrence of bacteremia with the same species after appropriate antimicrobial therapy and in the absence of an alternative source for bacteremia should prompt careful evaluation for CIED infection. (See  <a class="medical medical_review" href="/d/html/116021.html" rel="external">"Infections involving cardiac implantable electronic devices: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H901877797"><span class="h2">Fungemia</span><span class="headingEndMark"> — </span>Data on fungemia in patients with CIED are sparse. One systematic review of case reports and case series suggests that 90 percent of fungemias were associated with valve or lead involvement (as seen on echocardiography); CIED extraction was associated with increased survival to hospital discharge among cases where the device was removed versus retained (92 versus 54 percent) [<a href="#rid47">47</a>]. In another study including 12 patients with CIED and candidemia, mortality was higher among those who did not undergo CIED removal (88 versus 25 percent) [<a href="#rid48">48</a>]. However, because these patients are often immunosuppressed and chronically ill, the treatment strategy was likely confounded by the severity of illness. </p><p class="headingAnchor" id="H1282227080"><span class="h1">FORMS OF INFECTION</span></p><p class="headingAnchor" id="H3602044615"><span class="h2">CIED pocket infection</span></p><p class="headingAnchor" id="H1634682266"><span class="h3">Definition</span><span class="headingEndMark"> — </span>CIED pocket infection refers to infection involving the subcutaneous pocket containing the pulse generator and the subcutaneous segment of the leads, but not the transvenous segment of the leads  (<a class="graphic graphic_figure graphicRef118356" href="/d/graphic/118356.html" rel="external">figure 1</a>). Such patients generally have negative blood cultures and no evidence of a lead/valve vegetation on transesophageal echocardiogram (TEE).</p><p>Extension of CIED pocket infection to involve intravascular lead(s) can occur, leading to systemic infection (eg, concurrent positive blood cultures and/or evidence of a lead/valve vegetation on TEE). (See <a class="local">'CIED systemic infection'</a> below.)</p><p class="headingAnchor" id="H2198187209"><span class="h3">Pathogenesis</span><span class="headingEndMark"> — </span>The most common source of pocket infection is perioperative contamination with skin flora, which can result in acute or delayed-onset infection. This was illustrated in a prospective study including 103 patients undergoing elective pacemaker (PPM) implantation [<a href="#rid49">49</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Swab specimens (obtained from the pulse-generator pocket before and after insertion) yielded bacteria from 48 and 37 percent of specimens, respectively; the organisms were predominantly coagulase-negative staphylococci.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subsequent PPM infection developed in five patients (4.8 percent). <em>Staphylococcus schleiferi</em> (a coagulase-negative species) caused three of these infections at 4, 16, and 29 months after implantation, respectively. Based upon molecular typing, the <em>S. schleiferi</em> isolates recovered at insertion and at the time of the infection appeared identical.</p><p></p><p class="headingAnchor" id="H3831228523"><span class="h3">Clinical manifestations</span><span class="headingEndMark"> — </span>Infections involving the generator pocket typically develop soon after CIED implantation or pulse generator change. However, pocket infections can also arise many months after implantation due to a chronic, smoldering infection related to contamination at the time of implantation.</p><p>Patients with acute or subacute pocket infection may present with pocket discomfort, erythema of the overlying skin (eg, cellulitis), swelling, and occasionally drainage through a dehisced incision. Fever and systemic symptoms are often absent when infection is limited to the generator pocket [<a href="#rid50">50</a>]. However, patients with evident pocket infection who manifest a systemic inflammatory response (tachycardia, tachypnea, fever or hypothermia, and leukocytosis or leukopenia) and/or hypotension are at risk for concurrent blood stream infection [<a href="#rid51">51</a>] (see <a class="local">'CIED systemic infection'</a> below). In some patients, part of the device or lead erodes through the overlying skin  (<a class="graphic graphic_picture graphicRef74725" href="/d/graphic/74725.html" rel="external">picture 1</a>); this can occur in acute or delayed infection.</p><p>Patients with delayed pocket infection may present with the above findings or may present with minimal local inflammatory changes; in some cases, the sole clinical manifestation may be the erosion itself.</p><p>In the setting of erosion of the pulse generator or lead due to physical factors, site contamination is unavoidable; erosion of any part of the CIED unequivocally indicates that the device is contaminated and infected. Therefore, such cases should be managed as a pocket infection (even in the absence of overt evidence for infection or inflammation).</p><p class="headingAnchor" id="H4066581953"><span class="h3">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of CIED pocket infection should be suspected when there is inflammation overlying the implanted device (including erythema, swelling, warmth, pain, or tenderness), purulent drainage from the pocket, deformation of the pocket, adherence or threatened erosion  (<a class="graphic graphic_picture graphicRef74725" href="/d/graphic/74725.html" rel="external">picture 1</a>), or erosion of the device or lead through the skin. The absence of systemic symptoms does not exclude the possibility of a CIED pocket infection. The diagnosis of isolated CIED pocket infection is established by the presence of one or more of these manifestations in the setting of negative blood cultures and negative TEE [<a href="#rid52">52</a>]. The approach to evaluation of suspected pocket infection is summarized in the algorithm  (<a class="graphic graphic_algorithm graphicRef117258" href="/d/graphic/117258.html" rel="external">algorithm 1</a>).</p><p>In the absence of clinical signs of local inflammation, percutaneous aspiration of a pocket is not warranted; the diagnostic yield is generally low and there is a potential risk of introducing microorganisms. In the setting of prior antibiotic therapy, pocket infection may be obvious clinically, but pocket and blood cultures may be falsely negative. In the absence of prior antimicrobial therapy, negative Gram stains or culture of drainage may indicate infection due to an unusual organism (mycobacteria, fungi, etc); in such cases, detection might require assessment using special histopathologic and culture techniques.</p><p>In patients with overt pocket infection, draining purulent fluid should be cultured and blood cultures should be drawn (at least two or three sets), particularly if the patient manifests a systemic inflammatory response syndrome or is hypotensive. Thereafter, empiric antimicrobial therapy can be initiated. </p><p>At the time of device removal, the pocket swabs and tissue should be cultured. Sonication of the device with culture of the sonicate fluid has been found to be more sensitive than swab cultures of the device or pocket tissue. In addition, polymerase chain reaction (PCR) testing of the sonicate fluid further enhances sensitivity. While not widely available nor routine, sonicate fluid PCR may be diagnostic for patients who have received recent antibiotics or for circumstances in which difficult–to-culture organisms are anticipated [<a href="#rid53">53,54</a>].</p><p>In addition, chest radiography should be obtained to evaluate for evidence of septic pulmonary emboli, and a TEE should be obtained to evaluate for lead/valve vegetations. These studies are particularly important in evaluating patients in whom prior antibiotic therapy may have led to false-negative blood cultures.</p><p>In settings with suspected but less obvious pocket infection, fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) or radiolabeled autologous white blood cell single-photon emission computed tomogram with CT (SPECT/CT) scanning may be helpful to define pocket infection. (See <a class="local">'Diagnosis'</a> below.)</p><p>Of note, TEE imaging of chronic leads may demonstrate fibrous stranding arising from the lead [<a href="#rid55">55,56</a>]. In the absence of positive blood cultures, such findings should not be interpreted as infected vegetations.</p><p>The approach to empiric antibiotic therapy is discussed separately. (See  <a class="medical medical_review" href="/d/html/116021.html" rel="external">"Infections involving cardiac implantable electronic devices: Treatment and prevention", section on 'Empiric therapy'</a>.)</p><p class="headingAnchor" id="H2396382184"><span class="h3">Differential diagnosis</span><span class="headingEndMark"> — </span>Pocket infection must be distinguished from:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early superficial site infection</strong> – Early superficial site infection, such as a superficial stitch abscess, occurs within the initial 30 days after implantation and is localized to the superficial aspect of the wound (ie, does not extend to involve the pocket). In the absence of a stitch abscess, superficial infection may be difficult to distinguish from early pocket infection or early postimplantation inflammation (see below).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early postimplantation inflammation</strong> – Early postimplantation inflammation, a very rare event, occurs within the initial 30 days after implantation; it is associated with erythema of the skin abutting the incision but no purulent exudate, dehiscence, fluctuance, or systemic signs of infection. This entity does not represent infection; it may occur due to local bleeding, reaction to a wound dressing, or skin preparation. The manifestations generally resolve within two weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pocket hematoma </strong>– A CIED pocket hematoma consists of a blood collection within the pocket or, occasionally, collecting in the subpectoral space. Because the bleeding is due to the procedure, it usually occurs within the first 24 hours after implantation. A hematoma within either space typically leads to swelling and minimal discoloration of the skin, more suggestive of bruising than inflammation. Late occurrence of CIED pocket swelling (especially when remote from any procedure) should raise suspicion for pocket infection. </p><p></p><p>The difficulty in distinguishing the above entities from one another and from pocket infection may prompt evaluation using 18F-FDG-PET/CT, SPECT/CT or even empiric antimicrobial therapy (including coverage for <em>S. aureus</em>). On the assumption that the pocket is not infected in this situation, the device may be retained. If this strategy is pursued, very careful follow-up is essential to detect failure to respond or recurrence, which would suggest pocket and device infection.</p><p class="headingAnchor" id="H1324632276"><span class="h2">CIED systemic infection</span></p><p class="headingAnchor" id="H1484760"><span class="h3">Definition</span><span class="headingEndMark"> — </span>CIED systemic infection refers to infection involving the transvenous portion of the lead (with involvement of the contiguous endocardium or tricuspid valve) or an epicardial electrode (with involvement of the epicardium). CIED systemic infection can occur with or without involvement of the generator pocket. Patients with systemic infection generally have positive blood cultures and/or vegetation on TEE.</p><p>Synonyms for CIED systemic infection include lead infection and device-related endocarditis (CIED-IE).</p><p class="headingAnchor" id="H3143303352"><span class="h3">Pathogenesis</span><span class="headingEndMark"> — </span>Infection of the intravascular component of a CIED system (manifesting as an endocarditis-like vegetation) occurs primarily on the intracardiac portion of the lead along the right atrium, the tricuspid valve, or the right ventricular contact point. Occasionally, vegetations may be seen on the lead as it traverses from the superior vena cava into the right atrium. These infections may track intravascularly along the device lead from the subcutaneous pocket and device component or arise by bacteremic seeding from a remote site [<a href="#rid2">2,34,35,46</a>]. Seeding of the CIED from bacteremia primarily involves the intracardiac lead and is caused most commonly by <em>S. aureus. </em>(See <a class="local">'Bacteremia'</a> above.)</p><p>The host response to placement of the intravenous lead can provide protection from late bacteremic seeding. Approximately one week after placement, the portion of the lead in contact with the vein intima becomes partially incorporated into the vein wall by connective tissue and an endothelial covering. Fibrous tissue proliferation at some sites in the vena cava and right atrium results in a fibrotic attachment of the pacing lead to these points [<a href="#rid57">57,58</a>]. The endothelial covering may protect the lead against the adherence of bacteria and subsequent infection during episodes of bacteremia. While protective, these changes make subsequent extraction of pacing leads difficult. (See  <a class="medical medical_review" href="/d/html/971.html" rel="external">"Cardiac implantable electronic device lead removal"</a>.)</p><p>Epicardial electrodes may be infected at the cardiac attachment point as a result of intraoperative contamination or, less likely, by spread of infection along pacing electrodes from an infected pulse-generator pocket.</p><p class="headingAnchor" id="H12"><span class="h3">Clinical presentations</span><span class="headingEndMark"> — </span>Endocarditis (manifested as a lead vegetation and/or adjacent valve vegetation) is an important feature of CIED systemic infection [<a href="#rid34">34</a>]. The presence of vegetation(s) attached to the device lead (and/or contiguous endocardium) is termed device-related endocarditis (CIED-IE); these infections primarily involve the intracardiac portion of the lead and essentially represent a right-sided endocarditis. (See <a class="local">'Endocarditis'</a> below and <a class="local">'Lead vegetation'</a> below and <a class="local">'Valve vegetation'</a> below.)</p><p>Patients with infection of epicardial leads, particularly when those leads have been implanted at cardiac surgery, may present with concurrent mediastinitis or pericarditis. (See <a class="local">'Other presentations'</a> below.)</p><p class="headingAnchor" id="H277378477"><span class="h4">Endocarditis</span><span class="headingEndMark"> — </span>Up to half of patients with CIED-IE also have echocardiographic or intraoperative evidence of a vegetation on a valve (usually the tricuspid valve) [<a href="#rid3">3,33,59</a>]. Occasionally, echocardiography demonstrates isolated left-sided endocarditis or fails to demonstrate a vegetation in patients with CIED lead infection and high-grade bacteremia.</p><p>In one study including 45 patients with PPMs and endocarditis who underwent TEE, the following findings were observed [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>PPM endocarditis was observed in 33 patients. Concurrent valve involvement occurred in 16 patients (10 tricuspid, 6 aortic or mitral valves). The median interval from implantation to infection was 0.75 years (range 0.01 to 8 years). Multiple PPM procedures (generator changes) were common. Infection was caused by staphylococci in 70 percent of cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Valve infection (primarily left sided) without PPM involvement was observed in 12 patients. The median interval from implantation to infection was 2.2 years (range 0.08 to 7.2). Multiple PPM procedures were infrequent in this group. Infection was caused by staphylococci (42 percent) and less virulent organisms more typically associated with endocarditis such as streptococci, enterococci, and HACEK (<em>Haemophilus</em>, <em>Aggregatibacter</em>, <em>Cardiobacterium</em>, <em>Eikenella</em>, <em>Kingella</em>; 58 percent). </p><p></p><p>In another series of CIED infections including 51 patients with prosthetic valves, infection involved the pocket in 20 patients and the lead or valve in 31 (lead only in 15, valve only in 4, lead plus valve in 7, and occult bacteremia in 5) [<a href="#rid60">60</a>]. Similarly, in a study including 44 episodes of CIED-IE, 38 patients had device infection with or without valve leaflet involvement, and 6 had infection confined to the aortic or mitral valves [<a href="#rid59">59</a>].</p><p>Given that the TEE is not 100 percent sensitive for the detection of endocarditis, some patients with high-grade bacteremia due to typical endocarditis-causing organisms (defined as multiple [two or more] separate blood cultures positive for the same organism, drawn ≥1 hour apart) and a negative TEE will satisfy the modified Duke criteria for possible endocarditis and should be treated accordingly  (<a class="graphic graphic_algorithm graphicRef117257" href="/d/graphic/117257.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef131691" href="/d/graphic/131691.html" rel="external">algorithm 3</a>). By further evaluation with an alternative imaging technology (eg, electrocardiogram-gated cardiac computed tomography angiography [CTA], 18F-FDG-PET/CT, or SPECT/CT]) infection or endocarditis may be confirmed in some of these patients. The choice of a particular diagnostic modality will be guided by local availability and expertise. (See <a class="local">'Diagnosis'</a> below and  <a class="medical medical_review" href="/d/html/116021.html" rel="external">"Infections involving cardiac implantable electronic devices: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H991767258"><span class="h5">Lead vegetation</span><span class="headingEndMark"> — </span>Presence of a vegetation on the intracardiac lead seen on TEE (as opposed to fibrin stranding, which is found commonly on longstanding uninfected leads) may indicate infection of the CIED lead. Because of significant overlap in the appearance of infectious and noninfectious lead-adherent echodensities, the clinical scenario often determines the diagnosis and approach to treatment. For example, an echodensity found by TEE or intracardiac echo performed for an unrelated reason is unlikely to represent CIED infection or CIED-IE [<a href="#rid56">56</a>]. The clinical manifestations of lead infection are similar to those of right-sided endocarditis [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis", section on 'Clinical manifestations'</a>.)</p><p>Usually the presentation is subacute, but occasional patients present with sepsis syndrome and shock. The acute presentations are associated with more virulent organisms (eg,<em> S.</em> <em>aureus</em>). Manifestations overall include:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever – 84 to 100 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chills – 75 to 84 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary abnormalities – Clinical and/or radiographic findings consistent with pneumonia, bronchitis, lung abscess, or embolism occur in 20 to 45 percent of patients [<a href="#rid34">34,35</a>]. In particular, pulmonary embolism occurs in 11 to 40 percent of cases [<a href="#rid3">3,27,34,35,59</a>]. Abnormalities on chest imaging may provide indirect evidence of intracardiac lead or tricuspid valve infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tricuspid abnormalities – Tricuspid regurgitation develops in about 25 percent of patients; occasionally tricuspid stenosis results from an obstructing vegetation [<a href="#rid2">2,61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metastatic seeding of mitral or aortic valve, bone, joints, liver, and spleen [<a href="#rid59">59</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic emboli – Systemic emboli, including stroke, are rare but can occur in the setting of a patent foramen ovale, atrial septal defect, or unrecognized left-sided valve infection [<a href="#rid13">13</a>].</p><p></p><p>The clinical presentation of lead infection may be early onset (within three to six months of CIED implantation or generator change; approximately one-third of cases) or late onset (more than six months after CIED manipulation; approximately two-thirds of cases) [<a href="#rid3">3,33-35</a>]. </p><p>In general, patients with early-onset CIED infection are recognized promptly because of the frequent concurrence of systemic symptoms and associated generator pocket infection [<a href="#rid3">3,34,35</a>]. Among patients with late-onset CIED infection, the average interval from device manipulation to the onset of symptoms is 25 months, and the symptoms are often protean and consistent with endocarditis, resulting in a delayed diagnosis [<a href="#rid34">34,35</a>]. Clinical manifestations of endocarditis are discussed further separately. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2138.html" rel="external">"Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a>.)</p><p class="headingAnchor" id="H383761821"><span class="h5">Valve vegetation</span><span class="headingEndMark"> — </span>CIED infection can occur in association with concomitant infection of the right (or, less commonly, left) heart valves [<a href="#rid3">3,59,62</a>]. In addition, patients with a CIED may present with valvular endocarditis in the absence of device infection.</p><p>The most common symptoms of valvular endocarditis are fever and chills; other symptoms include malaise, headache, myalgias, arthralgias, night sweats, abdominal pain, dyspnea, cough, and pleuritic pain. Cardiac murmurs are observed in approximately 85 percent of patients. Signs specifically suggestive of left-sided valve infection include cutaneous manifestations such as petechiae or splinter hemorrhages and systemic emboli. (See  <a class="medical medical_review" href="/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2138.html" rel="external">"Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1509942054"><span class="h4">Other presentations</span><span class="headingEndMark"> — </span>Other presentations of CIED systemic infection include bacteremia with infection of remote sites, and in patients with epicardial leads, mediastinitis, and pericarditis.</p><p>Bacteremia associated with CIED lead infection may occur in the absence of clinical evidence for endocarditis. Occasionally, remote extravascular sites (eg, bone or joint) are seeded. In patients with a CIED who present with hematogenously seeded deep infection, the potential for concurrent CIED lead infection must be considered.</p><p>Symptoms of mediastinitis or pericarditis may occur in the setting of patients with infection of epicardial electrodes. Both are usually associated with bacteremia:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical manifestations of mediastinitis include fever and chest pain. (See  <a class="medical medical_review" href="/d/html/7014.html" rel="external">"Postoperative mediastinitis after cardiac surgery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical manifestations of pericarditis include fever, pleuritic chest pain, and pericardial friction rub. Pericardial effusion may be observed on echocardiogram or radiographic imaging and be accompanied by hemodynamic complications. (See  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H931392891"><span class="h3">Diagnostic evaluation</span><span class="headingEndMark"> — </span>The clinical presentation and results of initial tests determine the need to test for a CIED systemic infection as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients who require evaluation for CIED infection</strong> − Diagnostic testing for CIED systemic infection should be obtained in patients with a CIED who present with any of the following characteristics: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fever or other systemic signs of infection</p><p class="bulletIndent2"><span class="glyph">•</span>Overt pocket infection</p><p class="bulletIndent2"><span class="glyph">•</span>Pulmonary nodular infiltrates (eg, suspected septic emboli)</p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained bacteremia</p><p class="bulletIndent2"><span class="glyph">•</span>Bacteremia with <em>S. aureus</em></p><p></p><p class="bulletIndent1">The absence of signs or symptoms of CIED pocket infection does not rule out CIED systemic infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients who may not require evaluation for a CIED infection</strong> -− Diagnostic testing for CIED systemic infection may not be necessary for all patients with a CIED and bacteremia. Patients with a CIED and bacteremia from a clearly defined infection remote from the CIED (eg, pneumococcal pneumonia, pyelonephritis due to Enterobacteriaceae) caused by an organism not typically associated with intravascular infection are at low risk of CIED infection. In such patients, the infection can be treated and the patient can be monitored for signs of CIED infection during follow-up.</p><p></p><p class="headingAnchor" id="H408347892"><span class="h4">Evaluation for CIED infection</span><span class="headingEndMark"> — </span>The approach to evaluation of suspected CIED systemic infection is summarized in the algorithms  (<a class="graphic graphic_algorithm graphicRef117257" href="/d/graphic/117257.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef131691" href="/d/graphic/131691.html" rel="external">algorithm 3</a>) and includes the following tests:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood cultures</strong> − At least two sets of blood cultures should be obtained from separate venipuncture sites prior to initiation of empiric antimicrobial therapy [<a href="#rid1">1,52</a>].</p><p></p><p class="bulletIndent1">If bacteremia is detected, follow-up blood cultures should be obtained daily after antimicrobial therapy is begun and continued until 48 to 72 hours after clearance of bacteremia is documented. Frequent blood cultures may provide additional prognostic information in those with staphylococcal bacteremia and possible CIED infection; notably the risk of recurrence is associated with the duration of staphylococcal bacteremia [<a href="#rid41">41</a>]. The approach to empiric antibiotic therapy is discussed separately. (See  <a class="medical medical_review" href="/d/html/116021.html" rel="external">"Infections involving cardiac implantable electronic devices: Treatment and prevention", section on 'Empiric therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Echocardiography</strong> − In all patients with suspected CIED infection, echocardiography should be performed using an approach similar to the evaluation for valvular endocarditis (ie, initial transthoracic echocardiography [TTE] with a subsequent transesophageal echo [TEE] if the TTE is negative or additional information is required to direct management)  (<a class="graphic graphic_movie graphicRef74493" href="/d/graphic/74493.html" rel="external">movie 1</a>) [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1">TEE is better than transthoracic echocardiography for detection of lead and valve vegetations and also provides images of the lead in the proximal superior vena cava. In several studies, TEE identified vegetations on the tricuspid valve or device lead in 90 to 96 percent of patients with endocarditis; in contrast, TTE identified such findings in only 22 to 43 percent [<a href="#rid2">2,27,34,35,63</a>]. </p><p></p><p class="bulletIndent1">However, TEE cannot fully exclude the presence of CIED infection or endocarditis. Accordingly, when intracardiac infection is highly suspected and the TEE is negative, further testing is necessary (eg, repeat echocardiography or alternative imaging as described below)  (<a class="graphic graphic_algorithm graphicRef131691" href="/d/graphic/131691.html" rel="external">algorithm 3</a>). The limitations of TEE for discriminating between infectious lead vegetations and thrombus were demonstrated in small studies: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a small case-control study that blinded echocardiographers to all clinical data, infectious and noninfectious echodensities did not differ in their echocardiographic characteristics (eg, diameter, mobility), and the reviewers' ability to correctly diagnose infectious vegetations was low (sensitivity 34 percent) [<a href="#rid64">64</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Another study showed that 17 percent of patients undergoing TEE for noninfectious indications were found to have lead-based echodensities, and none of these patients manifested bacteremia during follow-up [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alternative imaging</strong> − When intracardiac infection is highly suspected in patients with a negative or nondiagnostic TEE, alternative imaging with SPECT [<a href="#rid65">65-67</a>] or FDG-PET/CT to support the diagnosis may be warranted [<a href="#rid67">67-73</a>]. These technologies can assess the entire device and may also detect infected sites remote from the device. These alternative imaging modalities are not routinely used in assessing CIED infection; they may be useful for situations when CIED infection has not been confirmed (but is strongly suspected) [<a href="#rid1">1,74</a>]. The choice of a particular diagnostic modality is guided by local availability and expertise: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><sup>1</sup><strong><sup>8F</sup></strong><strong>-FDG-PET/CT scan</strong> − PET positivity depends upon uptake of <sup>18</sup>F-FDG by inflammatory cells at the site of infection; its utility is uncertain in patients with leukopenia or after prolonged administration of antibiotics. <sup>18</sup>F-FDG-PET/CT technology may be useful for distinguishing infection of soft tissues overlying the generator from generator pocket infection and can define infection along the extracardiac course of electronic leads and within the heart [<a href="#rid67">67,69-72,75</a>]. In addition, <sup>18</sup>F-FDG-PET/CT can detect septic pulmonary emboli as a manifestation of lead-related endocarditis. Occasionally, this imaging may also demonstrate infection involving other sites due to bacteremia (such as vertebral osteomyelitis/discitis) or embolic events suggesting concurrent left-sided endocarditis (such as splenic or renal infarcts) [<a href="#rid67">67-71,73,74</a>].</p><p></p><p class="bulletIndent2">A meta-analysis including 340 patients noted a high overall sensitivity and specificity of <sup>18</sup>F-FDG-PET/CT for diagnosis of CIED infection (87 and 94 percent, respectively) [<a href="#rid73">73</a>]. However, the sensitivity and specificity were higher for pocket/generator infection (93 and 98 percent, respectively) compared with lead-associated endocarditis (65 and 88 percent, respectively). The findings of another meta-analysis including 492 patients were very similar [<a href="#rid76">76</a>]. Thus, radionuclide imaging, particularly FDG-PET/CT, is uniquely useful in assessing pocket infection but can also supplement diagnostic efforts for CIED-IE when echocardiography is equivocal.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tagged WBC scan</strong> − Scintigraphy (<sup>99m</sup>Tc-labeled white blood cell) and SPECT/CT have been used for the detection and localization of CIED infections [<a href="#rid66">66</a>]. SPECT/CT is able to locate inflammation better than scintigraphy, which has poor spatial resolution. SPECT/CT has good sensitivity for pocket infection. In patients with a suspected CIED infection and recent cardiac surgery, scintigraphy may be more specific than <sup>18</sup>F-FDG-PET/CT, which may be positive, particularly around implanted material, for two to three months after surgery due to sterile inflammation (false positive) [<a href="#rid68">68</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiac CT angiography (CCTA) </strong>– CCTA (with or without EKG gating), has poorer sensitivity than echocardiography for lead vegetations. It can be combined with enhanced chest CT to evaluate for pocket infection or hematogenous pulmonary findings which would indirectly support a diagnosis of CIED infection. Use of CCTA should be limited to situations in which radionuclide imaging is unavailable [<a href="#rid74">74</a>].</p><p></p><p class="headingAnchor" id="H397325147"><span class="h4">Evaluation for associated endocarditis</span><span class="headingEndMark"> — </span>Patients with a CIED who are undergoing evaluation for a CIED infection or who have unexplained bacteremia caused by an organism that commonly causes endocarditis are at high risk for right-sided or left-sided endocarditis; these patients should be evaluated for endocarditis, which typically includes a TEE. The approach to testing and interpretation of tests for endocarditis are discussed separately. (See  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Evaluation'</a>.)  </p><p class="headingAnchor" id="H2878258563"><span class="h3">Diagnosis</span></p><p class="headingAnchor" id="H2467919411"><span class="h4">Our approach</span><span class="headingEndMark"> — </span>The diagnosis of CIED systemic infection is established if a patient with a CIED has a fever or systemic signs of infection and one of the following  (<a class="graphic graphic_algorithm graphicRef117257" href="/d/graphic/117257.html" rel="external">algorithm 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Clinically evident pocket infection and positive blood cultures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TEE with valve or lead vegetation in the context of other signs and symptoms of systemic infection (as distinguished from fibrin stranding, which can be found on leads that have been in place over an extended period). Because of significant overlap in appearance between infectious and noninfectious vegetations, the clinical history, physical examination, and microbiology results supporting CIED infection should inform the interpretation of lead-based echodensities.</p><p></p><p class="bulletIndent1">In patients with nondiagnostic TEE or in whom TEE cannot be done, an alternative imaging modality (such as FDG-PET/CT, SPECT/CT, or CCTA) can identify evidence of CIED infection or endocarditis. The choice of a particular diagnostic modality will be guided by local availability and expertise. (See <a class="local">'Evaluation for CIED infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blood cultures demonstrate (see <a class="local">'Bacteremia'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Any isolation of the following organisms:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><em>S. aureus</em> (especially in the absence of a clear portal of entry, occurring within three months of device manipulation, or persisting or recurring in spite of appropriate antimicrobial therapy) (see <a class="local">'Bacteremia'</a> above)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><em>Candida</em> species</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>High-grade bacteremia (defined as 2 or more separate blood cultures positive for the same organism, drawn ≥1 hour apart) with the following organisms: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Coagulase-negative staphylococci. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) species. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Other high-grade bacteremia without clear portal of entry (especially due to an organism that commonly causes endocarditis, such as alpha-hemolytic streptococci, beta-hemolytic streptococci, enterococci). </p><p></p><p class="bulletIndent2">A single positive blood culture for coagulase-negative staphylococci o<em>r Cutibacterium</em> species may represent skin contamination. In such cases, blood cultures should be repeated to evaluate for high grade bacteremia. If repeat cultures are confounded by antibiotic therapy and clinical suspicion for CIED infection persists, consider pursuing further imaging (FDG-PET/CT) if available; further management should be guided by consultation with infectious disease expertise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Culture and histopathology of the vegetation/lead tip consistent with infection.</p><p></p><p class="headingAnchor" id="H3971068616"><span class="h4">Proposed diagnostic criteria</span><span class="headingEndMark"> — </span>The European Heart Rhythm Association proposed diagnostic criteria for CIED-IE modeled after the modified Duke Criteria for infective endocarditis; these criteria categorize cases into definite, possible, and rejected groups [<a href="#rid1">1</a>]. The criteria have not been validated, given the absence of a diagnostic "gold standard," but they provide a tool for systematic assessment for CIED-IE. The criteria use the above alternate imaging modalities as components of the classification schema; we agree with this approach.  </p><p class="headingAnchor" id="H20"><span class="h3">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of CIED-IE includes other causes of septic pulmonary emboli and causes of bacteremia in patients with a CIED that include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Septic jugular thrombophlebitis </strong>– Septic jugular thrombophlebitis is characterized by infectious involvement of the carotid sheath vessels with bacteremia (often with <em>Fusobacterium</em> spp); it should be suspected in patients with antecedent pharyngitis or parapharyngeal infection, septic pulmonary emboli, and persistent fever despite antimicrobial therapy. The diagnosis is established by computed tomography of the neck and upper thorax. (See  <a class="medical medical_review" href="/d/html/2131.html" rel="external">"Catheter-related septic thrombophlebitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lower extremity or pelvic vein thrombophlebitis </strong>– Patients with septic pelvic thrombophlebitis usually present shortly after delivery or surgery with fever in the absence of localizing symptoms, which persists despite antibiotics. Radiographic studies may or may not demonstrate thrombus and the diagnosis is often one of exclusion. (See  <a class="medical medical_review" href="/d/html/2130.html" rel="external">"Septic pelvic thrombophlebitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacteremia associated with a remote site of infection </strong>– Bacteremia (without involvement of the CIED) may occur from noncardiac sites such as the abdomen, pelvis, soft tissues, bone, or any prosthetic implant.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood culture contamination </strong>– Positive blood cultures do not always represent a true bacteremia; contamination with skin flora must be considered, particularly if the entire clinical picture does not suggest a systemic infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fibrous material associated with longstanding CIED leads </strong>– TEE may demonstrate fibrous material, clot, or stranding; these findings do not always represent infection [<a href="#rid55">55,56</a>].</p><p></p><p class="headingAnchor" id="H2219927492"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116384.html" rel="external">"Society guideline links: Infections involving cardiac implantable electronic devices"</a>.)</p><p class="headingAnchor" id="H38"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac implantable electronic devices (CIEDs) include pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy (CRT) devices with or without defibrillation capacity. The most important risk factor for CIED infection is recent manipulation of the device. The most common causes of CIED infection are <em>Staphylococcus aureus</em> and coagulase-negative staphylococci. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Forms of CIED infection include pocket infection and systemic infection. These categories are not mutually exclusive, and the two forms may coexist. (See <a class="local">'Forms of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CIED pocket infection refers to infection involving the subcutaneous pocket containing the pulse generator and the subcutaneous segment of the leads, but not the transvenous segment of the leads. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CIED pocket infection should be suspected when there is inflammation overlying the implanted device (including erythema, swelling, warmth, pain, and tenderness), purulent drainage from the pocket, deformation of the pocket, or erosion of the device or lead through the skin, in the absence of systemic symptoms. The diagnosis of isolated pocket infection is established by the presence of one or more of these manifestations in the setting of negative blood cultures and negative transesophageal echocardiography. The approach to evaluation of suspected pocket infection is summarized in the algorithm  (<a class="graphic graphic_algorithm graphicRef117258" href="/d/graphic/117258.html" rel="external">algorithm 1</a>). (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CIED systemic infection refers to infection involving the transvenous portion of the lead (particularly infection of the endocardial portion of the lead with involvement of the contiguous endocardium or tricuspid valve) or an epicardial electrode (with involvement of the epicardium). Endocarditis (due to lead vegetation and/or valve vegetation) is an important presentation of CIED systemic infection. Other presentations include bacteremia with infection of remote sites and, in patients with epicardial leads, mediastinitis and pericarditis. (See <a class="local">'Definition'</a> above and <a class="local">'Clinical presentations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of CIED systemic infection should be suspected in patients with a CIED who present with fever or other systemic symptoms of infection and have signs of a pocket infection, pulmonary nodular infiltrates (eg, suspected septic emboli), unexplained bacteremia, or bacteremia caused by <em>S. aureus</em>. The approach to evaluation of suspected CIED systemic infection is summarized in the algorithms  (<a class="graphic graphic_algorithm graphicRef117257" href="/d/graphic/117257.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef131691" href="/d/graphic/131691.html" rel="external">algorithm 3</a>). (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H1315608798"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Leonard Ganz, MD, FHRS, FACC, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020; 41:2012.</a></li><li><a class="nounderline abstract_t">Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 1994; 73:299.</a></li><li><a class="nounderline abstract_t">Duval X, Selton-Suty C, Alla F, et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004; 39:68.</a></li><li><a class="nounderline abstract_t">Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007; 167:669.</a></li><li><a class="nounderline abstract_t">Smith PN, Vidaillet HJ, Hayes JJ, et al. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators. Pacing Clin Electrophysiol 1998; 21:42.</a></li><li><a class="nounderline abstract_t">Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 1998; 27:265.</a></li><li><a class="nounderline abstract_t">Dai M, Cai C, Vaibhav V, et al. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC Clin Electrophysiol 2019; 5:1071.</a></li><li><a class="nounderline abstract_t">Rennert-May E, Chew D, Lu S, et al. Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study. Heart Rhythm 2020; 17:1125.</a></li><li class="breakAll">Eggimann P, Waldvogel F. Pacemaker and defibrillator infections. In: Infections Associated with Indwelling Medical Devices, Waldvogel FA, Bisno AL (Eds), American Society for Microbiology Press, Washington, DC 2000. p.247.</li><li><a class="nounderline abstract_t">Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011; 58:1001.</a></li><li><a class="nounderline abstract_t">Olsen T, Jørgensen OD, Nielsen JC, et al. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018). Eur Heart J 2019; 40:1862.</a></li><li><a class="nounderline abstract_t">Joy PS, Kumar G, Poole JE, et al. Cardiac implantable electronic device infections: Who is at greatest risk? Heart Rhythm 2017; 14:839.</a></li><li><a class="nounderline abstract_t">Khaloo P, Uzomah UA, Shaqdan A, et al. Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017. J Am Heart Assoc 2022; 11:e025600.</a></li><li><a class="nounderline abstract_t">Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 2014; 130:1037.</a></li><li><a class="nounderline abstract_t">Le KY, Sohail MR, Friedman PA, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011; 8:1678.</a></li><li><a class="nounderline abstract_t">Greenspon AJ, Eby EL, Petrilla AA, Sohail MR. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol 2018; 41:495.</a></li><li><a class="nounderline abstract_t">Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116:1349.</a></li><li><a class="nounderline abstract_t">Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29:142.</a></li><li><a class="nounderline abstract_t">Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009; 95:715.</a></li><li><a class="nounderline abstract_t">Sohail MR, Henrikson CA, Braid-Forbes MJ, et al. Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device. Am J Cardiol 2013; 112:1403.</a></li><li><a class="nounderline abstract_t">Birnie DH, Wang J, Alings M, et al. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. J Am Coll Cardiol 2019; 74:2845.</a></li><li><a class="nounderline abstract_t">Kewcharoen J, Kanitsoraphan C, Thangjui S, et al. Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis. J Arrhythm 2021; 37:635.</a></li><li><a class="nounderline abstract_t">Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015; 70:325.</a></li><li><a class="nounderline abstract_t">Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015; 17:767.</a></li><li><a class="nounderline abstract_t">Rattanawong P, Kewcharoen J, Mekraksakit P, et al. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis. J Cardiovasc Electrophysiol 2019; 30:1053.</a></li><li><a class="nounderline abstract_t">Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007; 45:166.</a></li><li><a class="nounderline abstract_t">Massoure PL, Reuter S, Lafitte S, et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol 2007; 30:12.</a></li><li><a class="nounderline abstract_t">Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49:1851.</a></li><li><a class="nounderline abstract_t">Narui R, Nakajima I, Norton C, et al. Risk Factors for Repeat Infection and Mortality After Extraction of Infected Cardiovascular Implantable Electronic Devices. JACC Clin Electrophysiol 2021; 7:1182.</a></li><li><a class="nounderline abstract_t">Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am 2002; 16:477.</a></li><li><a class="nounderline abstract_t">Lewis AB, Hayes DL, Holmes DR Jr, et al. Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 1985; 89:758.</a></li><li><a class="nounderline abstract_t">Esquer Garrigos Z, George MP, Vijayvargiya P, et al. Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria. Mayo Clin Proc 2019; 94:1268.</a></li><li><a class="nounderline abstract_t">Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm 2010; 7:1043.</a></li><li><a class="nounderline abstract_t">Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997; 95:2098.</a></li><li><a class="nounderline abstract_t">Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82:480.</a></li><li><a class="nounderline abstract_t">Mateos Gaitán R, Boix-Palop L, Muñoz García P, et al. Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study. Europace 2020; 22:1062.</a></li><li><a class="nounderline abstract_t">Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104:1029.</a></li><li><a class="nounderline abstract_t">Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010; 33:407.</a></li><li><a class="nounderline abstract_t">Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol 2015; 8:137.</a></li><li><a class="nounderline abstract_t">Chesdachai S, Baddour LM, Sohail MR, et al. Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia. Heart Rhythm 2022; 19:570.</a></li><li><a class="nounderline abstract_t">Nakajima I, Narui R, Tokutake K, et al. Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection. Heart Rhythm 2021; 18:752.</a></li><li><a class="nounderline abstract_t">Berge A, Arkel L, Nilson B, Rasmussen M. Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence. Infection 2022; 50:1517.</a></li><li><a class="nounderline abstract_t">Oh TS, Le K, Baddour LM, et al. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol 2019; 42:1331.</a></li><li><a class="nounderline abstract_t">Uslan DZ, Sohail MR, Friedman PA, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006; 43:731.</a></li><li><a class="nounderline abstract_t">Chesdachai S, Baddour LM, Sohail MR, et al. Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia. Open Forum Infect Dis 2022; 9:ofac444.</a></li><li><a class="nounderline abstract_t">Camus C, Leport C, Raffi F, et al. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 1993; 17:46.</a></li><li><a class="nounderline abstract_t">Baman JR, Medhekar AN, Jain SK, et al. Management of systemic fungal infections in the presence of a cardiac implantable electronic device: A systematic review. Pacing Clin Electrophysiol 2021; 44:159.</a></li><li><a class="nounderline abstract_t">Nakamura T, Narui R, Holmes B, et al. Candidemia in patients with cardiovascular implantable electronic devices. J Interv Card Electrophysiol 2021; 60:69.</a></li><li><a class="nounderline abstract_t">Da Costa A, Lelièvre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998; 97:1791.</a></li><li><a class="nounderline abstract_t">Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133:604.</a></li><li><a class="nounderline abstract_t">Esquer Garrigos Z, George MP, Khalil S, et al. Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection. Open Forum Infect Dis 2019; 6:ofz084.</a></li><li><a class="nounderline abstract_t">Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010; 121:458.</a></li><li><a class="nounderline abstract_t">Nagpal A, Patel R, Greenwood-Quaintance KE, et al. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol 2015; 115:912.</a></li><li><a class="nounderline abstract_t">Esquer Garrigos Z, Sohail MR, Greenwood-Quaintance KE, et al. Molecular Approach to Diagnosis of Cardiovascular Implantable Electronic Device Infection. Clin Infect Dis 2020; 70:898.</a></li><li><a class="nounderline abstract_t">Downey BC, Juselius WE, Pandian NG, et al. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin Electrophysiol 2011; 34:679.</a></li><li><a class="nounderline abstract_t">Patel NJ, Singleton MJ, Brunetti R, et al. Evaluation of lead-based echodensities on transesophageal echocardiogram in patients with cardiac implantable electronic devices. J Cardiovasc Electrophysiol 2023; 34:7.</a></li><li><a class="nounderline abstract_t">Cox JN. Pathology of cardiac pacemakers and central catheters. Curr Top Pathol 1994; 86:199.</a></li><li><a class="nounderline abstract_t">Spittell PC, Hayes DL. Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc 1992; 67:258.</a></li><li><a class="nounderline abstract_t">Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008; 83:46.</a></li><li><a class="nounderline abstract_t">Huang XM, Fu HX, Zhong L, et al. Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves. Circ Arrhythm Electrophysiol 2016; 9.</a></li><li><a class="nounderline abstract_t">Voet JG, Vandekerckhove YR, Muyldermans LL, et al. Pacemaker lead infection: report of three cases and review of the literature. Heart 1999; 81:88.</a></li><li><a class="nounderline abstract_t">Schulze MR, Ostermaier R, Franke Y, et al. Images in cardiovascular medicine. Aortic endocarditis caused by inadvertent left ventricular pacemaker lead placement. Circulation 2005; 112:e361.</a></li><li><a class="nounderline abstract_t">Victor F, De Place C, Camus C, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999; 81:82.</a></li><li><a class="nounderline abstract_t">George MP, Esquer Garrigos Z, Vijayvargiya P, et al. Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities. Clin Infect Dis 2021; 72:1938.</a></li><li><a class="nounderline abstract_t">Sohns JM, Bavendiek U, Ross TL, Bengel FM. Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging. Circ Cardiovasc Imaging 2017; 10.</a></li><li><a class="nounderline abstract_t">Erba PA, Sollini M, Conti U, et al. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovasc Imaging 2013; 6:1075.</a></li><li><a class="nounderline abstract_t">Ahmed FZ, James J, Memmott MJ, Arumugam P. Radionuclide Imaging of Cardiovascular Infection. Cardiol Clin 2016; 34:149.</a></li><li><a class="nounderline abstract_t">Chen W, Sajadi MM, Dilsizian V. Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections. JACC Cardiovasc Imaging 2018; 11:1679.</a></li><li><a class="nounderline abstract_t">Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012; 59:1616.</a></li><li><a class="nounderline abstract_t">Brinker J. Imaging for infected cardiac implantable electronic devices: a new trick for your pet. J Am Coll Cardiol 2012; 59:1626.</a></li><li><a class="nounderline abstract_t">Pizzi MN, Roque A, Fernández-Hidalgo N, et al. Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center. Circulation 2015; 132:1113.</a></li><li><a class="nounderline abstract_t">Calais J, Touati A, Grall N, et al. Diagnostic Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and White Blood Cell SPECT/Computed Tomography in Patients With Suspected Cardiac Implantable Electronic Device Chronic Infection. Circ Cardiovasc Imaging 2019; 12:e007188.</a></li><li><a class="nounderline abstract_t">Juneau D, Golfam M, Hazra S, et al. Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection: A Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging 2017; 10.</a></li><li><a class="nounderline abstract_t">Galea N, Bandera F, Lauri C, et al. Multimodality Imaging in the Diagnostic Work-Up of Endocarditis and Cardiac Implantable Electronic Device (CIED) Infection. J Clin Med 2020; 9.</a></li><li><a class="nounderline abstract_t">Jerónimo A, Olmos C, Vilacosta I, et al. Accuracy of 18F-FDG PET/CT in patients with the suspicion of cardiac implantable electronic device infections. J Nucl Cardiol 2022; 29:594.</a></li><li><a class="nounderline abstract_t">Mahmood M, Kendi AT, Farid S, et al. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol 2019; 26:958.</a></li></ol></div><div id="topicVersionRevision">Topic 2146 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32101604" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7984081" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pacemaker endocarditis. Report of 44 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15206055" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17420425" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9474647" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9709875" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31537337" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32087358" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32087358" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21867833" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31155647" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28315744" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Cardiac implantable electronic device infections: Who is at greatest risk?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36000421" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25081281" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21699855" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29411401" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17724263" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16492298" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19036758" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Risk factors and time delay associated with cardiac device infections: Leiden device registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23972346" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31806127" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34141016" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25355810" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25926473" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30938929" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17578774" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Risk factor analysis of permanent pacemaker infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17241309" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Pacemaker endocarditis: clinical features and management of 60 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17481444" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33812827" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Risk Factors for Repeat Infection and Mortality After Extraction of Infected Cardiovascular Implantable Electronic Devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12092483" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Infections of intracardiac devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3990326" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Update on infections involving permanent pacemakers. Characterization and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30894248" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20470904" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cardiac implantable electronic device infections: presentation, management, and patient outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9133520" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9723637" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pacemaker infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32390046" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11524397" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19793360" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25504648" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34923159" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33321197" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35538390" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31424091" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16912947" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36092830" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8353245" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33052591" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Management of systemic fungal infections in the presence of a cardiac implantable electronic device: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32048116" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Candidemia in patients with cardiovascular implantable electronic devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9603533" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Role of the preaxillary flora in pacemaker infections: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11033588" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30997366" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20048212" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25779615" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30944928" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Molecular Approach to Diagnosis of Cardiovascular Implantable Electronic Device Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21303389" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36317461" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Evaluation of lead-based echodensities on transesophageal echocardiogram in patients with cardiac implantable electronic devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8162711" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Pathology of cardiac pacemakers and central catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1545594" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Venous complications after insertion of a transvenous pacemaker.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18174000" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27635069" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10220551" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Pacemaker lead infection: report of three cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16365199" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Images in cardiovascular medicine. Aortic endocarditis caused by inadvertent left ventricular pacemaker lead placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10220550" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pacemaker lead infection: echocardiographic features, management, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32533828" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29222120" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24011775" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26590786" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Radionuclide Imaging of Cardiovascular Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30409329" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22538331" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22538332" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Imaging for infected cardiac implantable electronic devices: a new trick for your pet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26276890" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31291779" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Diagnostic Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and White Blood Cell SPECT/Computed Tomography in Patients With Suspected Cardiac Implantable Electronic Device Chronic Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28377468" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32674517" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Multimodality Imaging in the Diagnostic Work-Up of Endocarditis and Cardiac Implantable Electronic Device (CIED) Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32748277" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Accuracy of 18F-FDG PET/CT in patients with the suspicion of cardiac implantable electronic device infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28913626" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
